Beyond Rudder Lube and Ozone Holes: A Pharmaceutical Governance Framework for Frontier AI (Consolidated Policy Brief)

This consolidated policy brief critiques the two dominant regulatory metaphors in contemporary frontier AI governance: commercial aviation (FAA/EASA deterministic engineering checklists) and the 1987 Montreal Protocol (global phase-out of fungible industrial chemicals with drop-in commercial substitutes), demonstrating why both frameworks are ontologically mismatched to adaptive, context-sensitive deployed AI systems. Drawing on modern biomedical and psychopharmacological regulatory history—anchored by FDA pharmacologist Dr. Frances Oldham Kelsey's 1960–1962 refusal of thalidomide, the resulting 1962 Kefauver–Harris Drug Amendments requiring empirical proof of safety and efficacy prior to mass release, and the contemporary Risk Evaluation and Mitigation Strategies (REMS) used for thalidomide derivatives (lenalidomide, pomalidomide) in hematological oncology—this brief translates proven pharmaceutical instruments into an actionable regulatory architecture organized around the Therapeutic Index (TI = TD50 / ED50) and operator skill floors.Specifically, the framework establishes: (1) a Five-Tier Controlled Deployment Scheduling Ladder (Schedule I Prohibited, Schedule II / AI-REMS Controlled Dual-Use, Prescription Rx, Behind-the-Counter BTC, and Over-the-Counter OTC) with an automatic schedule elevation trigger and a lateral IND/IRB Research Safe Harbor decoupled from hyperscaler NDA vetoes; (2) mandatory Phase IV post-market pharmacovigilance anchored to a public, liability-shielded Adverse AI Event Registry (AAER) with five severity grades and binding reporting clocks (24 hours to monthly); (3) standardized Compound AI Black-Box Warnings and compounding-pharmacy formulation/marketing liability for third-party wrapper vendors (with user-threshold exemptions for small open-source deployments); and (4) jurisdictional pluralism accommodating U.S. informed-consent and closed-loop progressive reality-drift titration alongside EU precautionary difficulty floors, local-compute technical friction gates, and the Shulgin Cautionary Principle (PiHKAL/TiHKAL) protecting independent investigators. Finally, the brief outlines three structural caveats where the pharmaceutical analogy bends—zero-marginal-cost open-weight replication (the BitTorrent problem), Big-Tech regulatory capture and First Amendment bounds, and continuous cloud-substrate mutation resembling living biologics rather than small-molecule tablets.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24421095
Primary Topic
Ethics and Social Impacts of AI
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond Rudder Lube and Ozone Holes: A Pharmaceutical Governance Framework for Frontier AI (Consolidated Policy Brief)

Jesse Luke
Zenodo (CERN European Organization for Nuclear Research)
Ethics and Social Impacts of AI
article

Beyond Rudder Lube and Ozone Holes: A Pharmaceutical Governance Framework for Frontier AI (Consolidated Policy Brief)

Jesse Luke
article en

Abstract

This consolidated policy brief critiques the two dominant regulatory metaphors in contemporary frontier AI governance: commercial aviation (FAA/EASA deterministic engineering checklists) and the 1987 Montreal Protocol (global phase-out of fungible industrial chemicals with drop-in commercial substitutes), demonstrating why both frameworks are ontologically mismatched to adaptive, context-sensitive deployed AI systems. Drawing on modern biomedical and psychopharmacological regulatory history—anchored by FDA pharmacologist Dr. Frances Oldham Kelsey's 1960–1962 refusal of thalidomide, the resulting 1962 Kefauver–Harris Drug Amendments requiring empirical proof of safety and efficacy prior to mass release, and the contemporary Risk Evaluation and Mitigation Strategies (REMS) used for thalidomide derivatives (lenalidomide, pomalidomide) in hematological oncology—this brief translates proven pharmaceutical instruments into an actionable regulatory architecture organized around the Therapeutic Index (TI = TD50 / ED50) and operator skill floors.Specifically, the framework establishes: (1) a Five-Tier Controlled Deployment Scheduling Ladder (Schedule I Prohibited, Schedule II / AI-REMS Controlled Dual-Use, Prescription Rx, Behind-the-Counter BTC, and Over-the-Counter OTC) with an automatic schedule elevation trigger and a lateral IND/IRB Research Safe Harbor decoupled from hyperscaler NDA vetoes; (2) mandatory Phase IV post-market pharmacovigilance anchored to a public, liability-shielded Adverse AI Event Registry (AAER) with five severity grades and binding reporting clocks (24 hours to monthly); (3) standardized Compound AI Black-Box Warnings and compounding-pharmacy formulation/marketing liability for third-party wrapper vendors (with user-threshold exemptions for small open-source deployments); and (4) jurisdictional pluralism accommodating U.S. informed-consent and closed-loop progressive reality-drift titration alongside EU precautionary difficulty floors, local-compute technical friction gates, and the Shulgin Cautionary Principle (PiHKAL/TiHKAL) protecting independent investigators. Finally, the brief outlines three structural caveats where the pharmaceutical analogy bends—zero-marginal-cost open-weight replication (the BitTorrent problem), Big-Tech regulatory capture and First Amendment bounds, and continuous cloud-substrate mutation resembling living biologics rather than small-molecule tablets.

Zenodo (CERN European Organization for Nuclear Research)
Ethics and Social Impacts of AI
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon